Cargando…

Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide

Visceral hemangiosarcomas (HSA) are rare in cats and typically associated with aggressive biologic behavior and poor prognosis. A 4‐year‐old male neutered domestic shorthair cat was presented with a 3‐month history of hematuria and stranguria; ultrasonography identified a large bladder mass. Complet...

Descripción completa

Detalles Bibliográficos
Autores principales: McNally, Abigail, Rossanese, Matteo, Suárez‐Bonnet, Alejandro, Hardas, Alexandros, Yale, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365030/
https://www.ncbi.nlm.nih.gov/pubmed/37381579
http://dx.doi.org/10.1111/jvim.16750
_version_ 1785076964893130752
author McNally, Abigail
Rossanese, Matteo
Suárez‐Bonnet, Alejandro
Hardas, Alexandros
Yale, Andrew D.
author_facet McNally, Abigail
Rossanese, Matteo
Suárez‐Bonnet, Alejandro
Hardas, Alexandros
Yale, Andrew D.
author_sort McNally, Abigail
collection PubMed
description Visceral hemangiosarcomas (HSA) are rare in cats and typically associated with aggressive biologic behavior and poor prognosis. A 4‐year‐old male neutered domestic shorthair cat was presented with a 3‐month history of hematuria and stranguria; ultrasonography identified a large bladder mass. Complete excision was achieved by partial cystectomy. Histopathology and immunohistochemistry for von Willebrand factor confirmed HSA. The cat was treated using adjuvant cyclophosphamide, thalidomide, and meloxicam for 8 months. Abdominal ultrasonography repeated at 2 months and computed tomography repeated at 5 and 19 months after diagnosis showed no evidence of local recurrence or metastasis. The cat was alive at last follow‐up (896 days). Although the cat described in this report experienced a more favorable prognosis compared to other visceral HSA locations, additional cases are needed to further understand the biological behavior of bladder HSAs and guide treatment decisions.
format Online
Article
Text
id pubmed-10365030
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-103650302023-07-25 Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide McNally, Abigail Rossanese, Matteo Suárez‐Bonnet, Alejandro Hardas, Alexandros Yale, Andrew D. J Vet Intern Med SMALL ANIMAL Visceral hemangiosarcomas (HSA) are rare in cats and typically associated with aggressive biologic behavior and poor prognosis. A 4‐year‐old male neutered domestic shorthair cat was presented with a 3‐month history of hematuria and stranguria; ultrasonography identified a large bladder mass. Complete excision was achieved by partial cystectomy. Histopathology and immunohistochemistry for von Willebrand factor confirmed HSA. The cat was treated using adjuvant cyclophosphamide, thalidomide, and meloxicam for 8 months. Abdominal ultrasonography repeated at 2 months and computed tomography repeated at 5 and 19 months after diagnosis showed no evidence of local recurrence or metastasis. The cat was alive at last follow‐up (896 days). Although the cat described in this report experienced a more favorable prognosis compared to other visceral HSA locations, additional cases are needed to further understand the biological behavior of bladder HSAs and guide treatment decisions. John Wiley & Sons, Inc. 2023-06-28 /pmc/articles/PMC10365030/ /pubmed/37381579 http://dx.doi.org/10.1111/jvim.16750 Text en © 2023 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle SMALL ANIMAL
McNally, Abigail
Rossanese, Matteo
Suárez‐Bonnet, Alejandro
Hardas, Alexandros
Yale, Andrew D.
Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
title Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
title_full Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
title_fullStr Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
title_full_unstemmed Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
title_short Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
title_sort urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
topic SMALL ANIMAL
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365030/
https://www.ncbi.nlm.nih.gov/pubmed/37381579
http://dx.doi.org/10.1111/jvim.16750
work_keys_str_mv AT mcnallyabigail urinarybladderhemangiosarcomainacattreatedwithpartialcystectomyandadjuvantmetronomiccyclophosphamideandthalidomide
AT rossanesematteo urinarybladderhemangiosarcomainacattreatedwithpartialcystectomyandadjuvantmetronomiccyclophosphamideandthalidomide
AT suarezbonnetalejandro urinarybladderhemangiosarcomainacattreatedwithpartialcystectomyandadjuvantmetronomiccyclophosphamideandthalidomide
AT hardasalexandros urinarybladderhemangiosarcomainacattreatedwithpartialcystectomyandadjuvantmetronomiccyclophosphamideandthalidomide
AT yaleandrewd urinarybladderhemangiosarcomainacattreatedwithpartialcystectomyandadjuvantmetronomiccyclophosphamideandthalidomide